Structure-based design of Trifarotene, a potent and selective RAR agonist for the treatment of acne

被引：0

作者：

Thoreau, E. ^{[1
]}

Arlabosse, J. ^{[1
]}

Bouix-peter, C. ^{[2
]}

Chambon, S. ^{[1
]}

Chantalat, L. ^{[3
]}

Daver, S. ^{[1
]}

Dumais, L. ^{[1
]}

Duvert, G. ^{[1
]}

Feret, A. ^{[1
]}

Ouvry, G. ^{[4
]}

Pascau, J. ^{[4
]}

Raffin, C. ^{[1
]}

Rodeville, N. ^{[5
]}

Soulet, C. ^{[1
]}

Tabet, S. ^{[1
]}

Talano, S. ^{[1
]}

Portal, T. ^{[6
]}

机构：

[1] Nestle Skin Hlth, Biot, France

[2] Galderma R&D, Biot, France

[3] Nestle Skin Hlth, New York, NY USA

[4] Galderma R&D, Nestle Skin Hlth, Biot, France

[5] Virbac, Carros, France

[6] Galderma SA, Lausanne, Switzerland

来源：

JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2018年 / 138卷 / 09期

关键词：

D O I：

10.1016/j.jid.2018.06.107

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

LB1570

引用

页码：B17 / B17

页数：1

共 50 条

[1] Structure-based design of Trifarotene (CD5789), a potent and selective RARγ agonist for the treatment of acne
Thoreau, Etienne
Arlabosse, Jean-Marie
Bouix-Peter, Claire
Chambon, Sandrine
Chantalat, Laurent
Daver, Sebastien
Dumais, Laurence
Duvert, Gwenaelle
Feret, Angelique
Ouvry, Gilles
Pascau, Jonathan
Raffin, Catherine
Rodeville, Nicolas
Soulet, Catherine
Tabet, Samuel
Talano, Sandrine
Portal, Thibaud
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (10) : 1736 - 1741
[2] Non-clinical and human pharmacology of the potent and selective topical RARγ agonist trifarotene
Aubert, J.
Bertino, B.
Blanchet-Rethore, S.
Carlavan, I.
Deret, S.
Dreno, B.
Luzy, A.
Mounier, C.
Pascau, J.
Pelisson, I.
Portal, T.
Rivier, M.
Rosso, P.
Thoreau, E.
Vial, E.
Voegel, J. J.
[J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (09) : B17 - B17
[3] Structure-based design of potent and selective CGRP receptor antagonists for the treatment of migraine
Bell, Ian
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
[4] Structure-Based Design of Potent and Selective Inhibitors of Pyruvate Carboxylase
Schneider, Nicholas
Burkett, Daniel
Wyatt, Brittney
Mews, Mallory
Bautista, Anson
Engel, Ryan
Dockendorff, Chris
Donaldson, William
St Maurice, Martin
[J]. PROTEIN SCIENCE, 2021, 30 : 141 - 141
[5] Structure-Based Design of a Potent and Selective YTHDC1 Ligand
Zalesak, Frantisek
Nai, Francesco
Herok, Marcin
Bochenkova, Elena
Bedi, Rajiv K.
Li, Yaozong
Errani, Francesco
Caflisch, Amedeo
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (11) : 9516 - 9535
[6] Structure-Based Design of Potent and Selective CK1γ Inhibitors
Huang, Hongbing
Acquaviva, Lisa
Berry, Virginia
Bregman, Howard
Chakka, Nagasree
O'Connor, Anne
DiMauro, Erin F.
Dovey, Jennifer
Epstein, Oleg
Grubinska, Barbara
Goldstein, Jon
Gunaydin, Hakan
Hua, Zihao
Huang, Xin
Huang, Liyue
Human, Jason
Long, Alex
Newcomb, John
Patel, Vinod F.
Saffran, Doug
Serafino, Randy
Schneider, Steve
Strathdee, Craig
Tang, Jin
Turci, Susan
White, Ryan
Yu, Violeta
Zhao, Huilin
Wilson, Cindy
Martin, Matthew W.
[J]. ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (12): : 1059 - 1064
[7] Structure-Based Design of Potent and Selective Ligands at the Four Adenosine Receptors
Jespers, Willem
Oliveira, Ana
Prieto-Diaz, Ruben
Majellaro, Maria
Aqvist, Johan
Sotelo, Eddy
Gutierrez-de-Teran, Hugo
[J]. MOLECULES, 2017, 22 (11):
[8] Structure-based design of selective and potent inhibitors of protein-tyrosine phosphatase β
Lund, IK
Andersen, HS
Iversen, LF
Olsen, OH
Moller, KB
Pedersen, AK
Ge, Y
Holsworth, DD
Newman, MJ
Axe, FU
Moller, NPH
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (23) : 24226 - 24235
[9] Structure-based design of potent and selective tankyrase inhibitors to target the Wnt pathway
Chakka, Nagasree
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
[10] Structure-based design of potent CDK4 selective inhibitor.
Honma, T
Hayashi, K
Kawanishi, N
Yoshizumi, T
Hashimoto, N
Sugimoto, T
Nakamura, K
Takaki, T
Machida, T
Fukasawa, K
Hirai, H
Iwama, T
Ikeura, C
Ikuta, M
Kamata, K
Suzuki-Takahashi, I
Hayama, T
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U24 - U24

← 1 2 3 4 5 →